MIM PHARMA AS
Signals
- Negativ egenkapital 2025 Bokført egenkapital er negativ (−615k kr).
- Driftsunderskudd 2025 Siste driftsresultat er negativt (−361k kr).
MIM PHARMA AS is registered as a limited company in Oslo, Oslo with organisation number 911618397. The business is classified under research and experimental development on natural sciences and engineering (NACE 72.100). The company was incorporated in 2013. Registered share capital is NOK 60,000, divided into 200 shares. The company's stated purpose is: “Forskning og utvikling innen bioteknologi og med fokus på nye farmasøytiske produkter, import, eksport, produksjon, distribusjon og videresalg av produkter knyttet til virksomheten.”. The most recent filed accounts, for the 2025 financial year, show NOK 0 in revenue and NOK −361,000 in operating profit.
Former names: LA RAMBLA AS, FERTIPOWER NORWAY AS, MIM DAROO NORWAY AS
Key figures · 2025
Financial health · 2025
Solidity capped at Weak because equity is below NOK 100,000.
Who owns MIM PHARMA AS?
MIM PHARMA AS has 3 registered shareholders:
- Peter Bahram Ressalehi 50.0%
- REZA RAMAZANI KHORSHIDDOUST 25.0%
- SALEH RAMAZANI KHORSHIDDOUST 25.0%
Frequently asked questions about MIM PHARMA AS
Who owns MIM PHARMA AS?
Peter Bahram Ressalehi is the largest registered owner, with 50.0%.
What is the revenue of MIM PHARMA AS?
MIM PHARMA AS had revenue of NOK 0 in 2025.
Who is the general manager of MIM PHARMA AS?
Jeanette Ressalehi is registered as general manager of MIM PHARMA AS.
Where is MIM PHARMA AS based?
MIM PHARMA AS has its business address in Oslo.
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 03.10.2026.